Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123946322 | 12394632 | 2 | F | 2015 | 20150629 | 20160523 | 20160728 | PER | US-MYLANLABS-2015M1022728 | MYLAN | 0.00 | F | Y | 100.23000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123946322 | 12394632 | 1 | PS | Albuterol Sulfate Inhalation Solution | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 0.63 MG, BID | 20949 | .63 | MG | NEBULISER SOLUTION | BID | ||||||
| 123946322 | 12394632 | 2 | SS | Albuterol Sulfate Inhalation Solution | ALBUTEROL SULFATE | 1 | 20949 | NEBULISER SOLUTION | |||||||||||
| 123946322 | 12394632 | 3 | SS | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 200 ?G, QD | 0 | 200 | UG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123946322 | 12394632 | 1 | Pulmonary hypertension |
| 123946322 | 12394632 | 2 | Off label use |
| 123946322 | 12394632 | 3 | Thyroid disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123946322 | 12394632 | Alopecia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123946322 | 12394632 | 3 | 2015 | 0 |